HSV-2 spreads through skin-to-skin contact, primarily during sexual activity. Most transmission happens during asymptomatic shedding when no visible symptoms are present. Condoms reduce risk by around 65-96%. Suppressive antiviral therapy reduces viral shedding by about 80% and transmission risk by approximately 48%, according to Corey et al. (NEJM, 2004). Combined, they're significantly more protective than either alone.
Key Transmission Facts
- Annual risk without protection: ~10% male-to-female, ~4-5% female-to-male
- Asymptomatic shedding occurs on roughly 10-15% of days on average
- Suppressive therapy reduces shedding by ~80% and transmission risk by ~48%
- Condoms reduce risk by ~96% (female to male) and ~65% (male to female)
- Combined condoms and suppressive therapy: ~75%+ risk reduction
- HSV-2 does not survive on surfaces -- cannot spread from toilet seats or towels
How HSV-2 actually spreads
Let's get specific about this, because "skin-to-skin contact" sounds vague and it's worth understanding the mechanics. HSV-2 is transmitted when virus particles present on the surface of infected skin or mucous membranes come into contact with a small break in the skin or a mucous membrane of another person. The virus then enters, travels to the nerve endings, and establishes itself there.
This happens most often during vaginal or anal sex. It can also happen through genital-to-genital contact without penetration, and in some cases through manual contact if someone touches infected tissue and then touches their own genital area. Oral-genital transmission is possible but uncommon for HSV-2 specifically.
What doesn't transmit HSV-2
The virus does not survive well outside the human body. You cannot get HSV-2 from:
- Toilet seats
- Towels or bedding
- Shared dishes or utensils
- Swimming pools or hot tubs
- Hugging or casual touching
- Shaking hands
Anyone telling you that HSV-2 can spread through these routes is misinformed. The biology doesn't support it. The virus needs direct skin contact with vulnerable tissue.
Asymptomatic shedding: the real driver of transmission
This is the most important thing to understand about HSV-2 transmission, and what makes it genuinely different from infections that only spread when you have obvious symptoms.
Even when there are no sores, no symptoms, no redness -- when everything looks completely normal -- the herpes virus can be active on the skin surface and transmissible to a partner. This is asymptomatic viral shedding, and it accounts for a large proportion of HSV-2 transmissions.
Research from the University of Washington lab (one of the leading centers for HSV research) has shown that people with HSV-2 shed virus asymptomatically on roughly 10-15% of days on average. This varies a lot between individuals. During the first year after initial infection, shedding tends to be more frequent. It decreases over time but continues throughout life.
Here's why this matters so much: this is why many people who transmit HSV-2 to partners genuinely didn't know they had it. They weren't lying. They had no symptoms, assumed they were clear, and potentially never knew they had the virus at all. According to CDC data, about 87% of HSV-2 positive people are undiagnosed. That's the real story behind most transmissions.
Suppressive antiviral therapy is particularly valuable here. Daily valacyclovir reduces asymptomatic shedding by about 80%, according to research published in the New England Journal of Medicine. That's a substantial reduction in one of the main transmission mechanisms.
Actual transmission risk numbers
These figures come from studies of heterosexual couples in serodiscordant relationships (one partner HSV-2 positive, one negative) over at least one year:
| Scenario | Annual transmission risk | Source |
|---|---|---|
| No protection, male-to-female transmission | ~10% per year | Corey et al., NEJM 2004 |
| No protection, female-to-male transmission | ~4-5% per year | Corey et al., NEJM 2004 |
| Consistent condom use (all scenarios) | ~50-65% risk reduction | CDC / Wald et al. |
| Daily suppressive therapy (valacyclovir) | ~48% risk reduction | Corey et al., NEJM 2004 |
| Condoms + suppressive therapy combined | ~75% or greater risk reduction | Combined studies |
To put the numbers in real terms: in a relationship where one partner has HSV-2 and neither partner uses protection, a female partner faces roughly a 1-in-10 annual chance of acquiring the virus. That's meaningful but not inevitable, especially when protection strategies are used.
With both consistent condom use and suppressive therapy, the risk drops to something around 1-3% per year. Many serodiscordant couples have been together for years -- sometimes a decade or more -- without transmission occurring. It's not a given.
Important context: These risk figures are based on studies of heterosexual couples having vaginal sex. Risk for receptive anal sex is higher. These are annual rates, not per-act rates. Shedding frequency, frequency of sex, and consistency of condom use all affect individual risk.
Condom effectiveness for HSV-2
Condoms reduce HSV-2 transmission risk, but not as dramatically as they do for some other STIs, and the reason is straightforward: HSV-2 can be present on skin that condoms don't cover. The inner thighs, the base of the penis, the vulva, the scrotum -- these areas can shed the virus and aren't covered by a standard condom.
The research shows consistent condom use reduces female-to-male transmission by roughly 96% and male-to-female transmission by roughly 65%. The difference between directions is partly because female genital tissue is more susceptible to the virus, and because there's more uncovered skin surface area involved.
The takeaway: condoms are absolutely worth using. They're effective, they protect against many other STIs, and combined with suppressive therapy they provide substantial protection. Just don't assume a condom makes HSV-2 transmission impossible -- it reduces risk, not eliminates it.
Oral sex and HSV-2
Can HSV-2 be transmitted through oral sex? Yes, in both directions, but this is less common than genital transmission.
HSV-2 oral transmission (receiving oral sex from someone with genital HSV-2 and acquiring it orally) is possible but uncommon. HSV-2 strongly prefers the sacral ganglion -- the nerve cluster near the base of the spine that services the genital area. It doesn't establish as readily in the trigeminal ganglion that serves the oral area, which is where HSV-1 typically lives.
In practice, genital HSV-2 infections acquired via oral sex are much less common than HSV-1 genital infections acquired the same way. But it's not impossible. If you have oral herpes concerns, using dental dams or condoms during oral sex reduces risk.
The more common oral-genital story with herpes is actually HSV-1 going in the other direction: someone with oral HSV-1 (cold sores) giving oral sex and transmitting HSV-1 to a partner's genitals. For more on that, see our HSV-1 vs HSV-2 comparison page.
What actually reduces transmission risk
The evidence-based strategies, in rough order of impact:
- Suppressive antiviral therapy: Daily medication reduces shedding by approximately 80% and transmission risk by approximately 48%. This is the single most evidence-backed intervention for reducing transmission to partners.
- Condoms: Reduce transmission risk, especially female-to-male. Not complete protection but meaningful reduction. Also protect against other STIs.
- Avoiding sex during outbreaks: Having sex when active sores are present is the highest-risk situation. This is the one case where the virus is definitely on the surface in significant amounts.
- Avoiding sex during prodrome: The warning signs (tingling, itching, burning) before an outbreak also indicate elevated viral activity. This period carries higher transmission risk than ordinary asymptomatic days.
- Knowing your status and your partner's status: This sounds obvious but most transmission happens when one person doesn't know they're infected. Testing matters. See our testing guide for how to get an accurate result.
The combination of suppressive therapy and consistent condoms is substantially more protective than either alone. For many couples, this combination makes transmission risk low enough that they don't let it dominate their relationship. See our disclosure guide for how to have this conversation with a partner.
The first year and long-term patterns
Transmission risk and shedding frequency aren't constant over time. The first year after initial HSV-2 infection tends to have the highest shedding frequency -- your immune system is still adapting to the virus. Research suggests shedding rates can be roughly twice as high in the first year compared to later years.
Over time, most people's immune systems become more effective at controlling the virus between outbreaks. Outbreak frequency decreases for most people after the first couple of years. Shedding frequency typically decreases as well, though it never reaches zero.
This is relevant for decisions about suppressive therapy: some people with infrequent outbreaks wonder whether daily medication is worth it long-term. The answer depends on whether you have partners to protect and how much the residual shedding risk matters to you. Suppressive therapy is effective and safe for long-term use, so there's no reason to stop on account of safety if it's helping. But it's a personal decision.
Frequently asked questions
Can HSV-2 spread without any symptoms?
Yes. Asymptomatic viral shedding is responsible for the majority of HSV-2 transmissions. The virus can be present on the skin surface and transmissible even with no visible sores. Average shedding occurs on about 10-15% of days. Suppressive therapy reduces this by about 80%.
Do condoms prevent HSV-2 transmission?
Condoms significantly reduce but don't eliminate HSV-2 transmission risk. Research shows consistent condom use reduces female-to-male transmission by about 96% and male-to-female by about 65%. HSV-2 can be present on skin not covered by a condom, which is why protection isn't complete.
What is the risk of getting HSV-2 from a positive partner?
Without any protection, annual transmission rates in discordant couples are approximately 10% male-to-female and 4-5% female-to-male, based on data from Corey et al. (NEJM, 2004). With both condoms and suppressive therapy, risk drops to roughly 1-3% per year or less.
Can HSV-2 spread through oral sex?
It's possible but uncommon. HSV-2 can potentially be transmitted to the mouth during oral sex, though oral HSV-2 infections are much less common than oral HSV-1. The virus strongly prefers the sacral nerve pathway serving the genital area.
Can you get HSV-2 from a toilet seat or shared towel?
No. HSV-2 doesn't survive well outside the body on surfaces. Transmission requires direct skin-to-skin contact with infected tissue. You can't get it from toilet seats, towels, pools, or casual contact.
How much does suppressive therapy reduce transmission risk?
Suppressive therapy with valacyclovir reduces transmission risk by approximately 48%, based on a randomized controlled trial published in the New England Journal of Medicine (Corey et al., 2004). It also reduces asymptomatic viral shedding by about 80%. Combined with condoms, the total risk reduction exceeds 75%.
Related: Treatment options | Valacyclovir for suppressive therapy | How to disclose to a partner | Testing guide